Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-795-0 | CAS number: 593-51-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
NOAEL was considered to be 500 mg/kg bw/day for P1 generation and 1000 mg/kg bw/day for F1 generation whenmale and female rats were treated withMethylaminehydrochloride (Methanaminium chloride) orally by gavage for 110 days.
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Justification for type of information:
- Data is from U.S. Environmental Protection Agency report
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Principles of method if other than guideline:
- Combined repeated dose repro-devp. Screen of Methylamine hydrochloride in rat
- GLP compliance:
- not specified
- Limit test:
- no
- Specific details on test material used for the study:
- - Name of test material: Methylamine hydrochloride (MAH)
- IUPAC name: Methanaminium chloride
- Molecular formula: CH5NCl H
- Molecular weight: 67.5184 g/mole
- Substance type: Organic - Species:
- rat
- Strain:
- not specified
- Details on species / strain selection:
- No data available
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- No data available
- Route of administration:
- oral: gavage
- Type of inhalation exposure (if applicable):
- not specified
- Vehicle:
- water
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: Methylamine hydrochloride was dissolved in water to give a dose of 0, 250, 500 and 1000 mg/Kg bw
DIET PREPARATION
- Rate of preparation of diet (frequency): No data available
- Mixing appropriate amounts with (Type of food): No data available
- Storage temperature of food: No data available
VEHICLE
- Justification for use and choice of vehicle (if other than water): Water
- Concentration in vehicle: 0, 250, 500, or 1000 mg/kg/day
- Amount of vehicle (if gavage): No data available
- Lot/batch no. (if required): No data available
- Purity: No data available - Details on mating procedure:
- - Length of cohabitation: 2 weeks
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- Total:110
Premating period -71 days
Mating period-14 days
Gestation period-21 days
Postpartum day -4. - Frequency of treatment:
- Daily
- Details on study schedule:
- No data available
- Remarks:
- 0, 250, 500 and 1000 mg/kg bw/day
- No. of animals per sex per dose:
- Total no of animals-96
0 mg/kg/day - 12 male and 12 female
250 mg/kg/day- 12 male and 12 female
500 mg/kg/day- 12 male and 12 female
1000 mg/kg/day- 12 male and 12 female - Control animals:
- yes, concurrent vehicle
- Details on study design:
- No data available
- Positive control:
- No data available
- Parental animals: Observations and examinations:
- Body weight and food consumption was observed.
- Oestrous cyclicity (parental animals):
- Any irregularity in estrous cycle were observed.
Implantation sites and ovarian corpora lutea also examined. - Sperm parameters (parental animals):
- No data available
- Litter observations:
- Pup viability, individual pup weights, litter sizes.and clinical signs were observed at birth and on lactation day 4.
- Postmortem examinations (parental animals):
- Gross pathology and histopathology were examined.
A histological examination of all tissues saved was conducted for all animals in the control and 1000 mg/kg/day group. Tissue examination in the other groups was limited to relevant gross lesions and tissues demonstrating treatment-related histological effects at 1000 mg/kg/day - Postmortem examinations (offspring):
- No data available.
- Statistics:
- No data available.
- Reproductive indices:
- Corpora Luta Counts and Mean Number of Pups/Litter were examined.
- Offspring viability indices:
- Offspring viability indices was observed on day 0 and 4 of lactation.
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality:
- not specified
- Body weight and weight changes:
- not specified
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Histopathological findings: non-neoplastic:
- not specified
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- not specified
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality:
- not specified
- Body weight and weight changes:
- effects observed, non-treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Neuropathological findings:
- not specified
- Histopathological findings: non-neoplastic:
- not specified
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
- Details on results:
- Body weight: Significant reductions in body weight in P1 animals were observed at 1000 mg/kg/day. Weight gain of pregnant females was less at 1000 mg /kg/day from gestational day 1 to day 7 (87.5% of control) but similar to the other groups at intervals after gestational day 7.
Food consumption: Significant reductions in food consumption were observed in P1 male and female rats. - Reproductive function: oestrous cycle:
- effects observed, treatment-related
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- no effects observed
- Dose descriptor:
- NOAEL
- Effect level:
- 500 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- body weight and weight gain
- food consumption and compound intake
- reproductive function (oestrous cycle)
- reproductive performance
- other: No adverse effect
- Critical effects observed:
- not specified
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- not specified
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Histopathological findings:
- not specified
- Other effects:
- not specified
- Behaviour (functional findings):
- not specified
- Developmental immunotoxicity:
- not specified
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- viability
- other: No adverse effect
- Critical effects observed:
- not specified
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality / viability:
- not specified
- Body weight and weight changes:
- not specified
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Histopathological findings:
- not specified
- Other effects:
- not specified
- Behaviour (functional findings):
- not specified
- Developmental immunotoxicity:
- not specified
- Reproductive effects observed:
- no
- Treatment related:
- not specified
- Relation to other toxic effects:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
- Conclusions:
- NOAEL was considered to be 500 mg/kg bw/day for P generation and 1000 mg/kg bw/day for F1 generation when male and female rats were treated with Methylamine hydrochloride (Methanaminium chloride) orally by gavage for 110 days.
- Executive summary:
In a repeated dose reproduction –development toxicity study, male and female rats were treated withMethylaminehydrochloride (Methanaminium chloride) in the concentration of0, 250, 500 and 1000 mg/kg/day orally by gavage in water. Test was conducted as per OECD 422. Significant decrease in body weight of P1 animals were observed at 1000 mg/kg/day. Weight gain of pregnant females was less at 1000 mg /kg/day from gestational day 1 to day 7 (87.5% of control) but similar to the other groups at intervals after gestational day 7. Significant reductions in food consumption were observed in P1 male and female rats. Similarly, reproductive toxicity was observed in treated female rats at 1000 mg/kg bw such as significant decrease in corpora lutea counts and subsequently lower implantation site counts and litter sizes were observed at 1000 mg/kg/day treated female rat. But, No effect on Number of Pups/Litter were observed in treated female rats. In addition, No effect on viability of treated pups were observed till day 4 of lactation as compared to control at 250, 500 and 1000 mg/kg bw/day. Therefore, NOAEL was considered to be 500 mg/kg bw/day for P generation and 1000 mg/kg bw/day for F1 generation whenmale and female rats were treated withMethylaminehydrochloride (Methanaminium chloride) orally by gavage for 110 days.
Reference
Reproductive performance: No effect on Number of Pups/Litter were observed in treated female rats.
MATBRNAL GROUP: |
II-0 |
IV-0 |
VI-0 |
VIII-0 |
DOSAGB{MG/KG/DAY): |
0 |
250 |
500 |
1000 |
CORPORA LUTEA COUNTS |
14.8 |
14.5 |
15.1 |
11.4* |
Standard Deviation(No. in group) |
2.3(12) |
2.1(11) |
1.8 (12) |
3.3(10) |
MEAN NUMBER OF PUPS/LITTER |
|
|
|
|
Born |
12.8 |
13.2 |
13.9 |
9.8 |
Born Alive |
12.8 |
13.0 |
13.9 |
9.8 |
Day 4 |
12.8 |
12.0 |
13.9 |
9.7 |
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 500 mg/kg bw/day
- Study duration:
- chronic
- Species:
- rat
- Quality of whole database:
- Data is Klimisch 4 and from study report
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Toxicity to reproduction: oral
In study, Methanaminium chloride has been investigated for reproductive toxicity. Study based on in vivo experiment in rodents, i.e. most commonly in rats for Methanaminium chloride.
In a experimental study by American Chemistry Council (U.S. Environmental Protection Agency, Document Processing Centre, Mail Code 7407, April 6, 2006), male and female rats were treated withMethylaminehydrochloride (Methanaminium chloride) in the concentration of0, 250, 500 and 1000 mg/kg/day orally by gavage in water. Test was conducted as per OECD 422 to Screen repeated dose reproduction –development toxicity. Significant decrease in body weight of P1 animals were observed at 1000 mg/kg/day. Weight gain of pregnant females was less at 1000 mg /kg/day from gestational day 1 to day 7 (87.5% of control) but similar to the other groups at intervals after gestational day 7. Significant reductions in food consumption were observed in P1 male and female rats. Similarly, reproductive toxicity was observed in treated female rats at 1000 mg/kg bw such as significant decrease in corpora lutea counts and subsequently lower implantation site counts and litter sizes were observed at 1000 mg/kg/day treated female rat. But, No effect on Number of Pups/Litter were observed in treated female rats. In addition, No effect on viability of treated pups were observed till day 4 of lactation as compared to control at 250, 500 and 1000 mg/kg bw/day. Therefore, NOAEL was considered to be 500 mg/kg bw/day for P1 generation and 1000 mg/kg bw/day for F1 generation whenmale and female rats were treated withMethylaminehydrochloride (Methanaminium chloride) orally by gavage for 110 days.
Thus, based on the above study on Methanaminium chloride and by applying the weight of evidence, Methanaminium chloride can be “Not classified” for reproductive toxicity.
Effects on developmental toxicity
Description of key information
NOAEL was considered to be 500 mg/kg bw/day for P generation and 1000 mg/kg bw/day for F1 generation when male and female rats were treated with Methylaminehydrochloride (Methanaminium chloride) orally by gavage for 110 days.
Link to relevant study records
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Justification for type of information:
- Data is from U.S. Environmental Protection Agency report
- Qualifier:
- according to guideline
- Guideline:
- other: OECD 422 guideline (combined repeat dose study with a reproductive/developmental screen)
- Principles of method if other than guideline:
- Combined repeated dose repro-devp. Screen of Methylamine hydrochloride in rat
- GLP compliance:
- not specified
- Limit test:
- no
- Specific details on test material used for the study:
- - Name of test material: Methylamine hydrochloride (MAH)
- IUPAC name: Methanaminium chloride
- Molecular formula: CH5NCl H
- Molecular weight: 67.5184 g/mole
- Substance type: Organic - Species:
- rat
- Strain:
- not specified
- Details on test animals or test system and environmental conditions:
- Sex: Male and female
- Route of administration:
- oral: gavage
- Type of inhalation exposure (if applicable):
- not specified
- Vehicle:
- water
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: Methylamine hydrochloride was dissolved in water to give a dose of 0, 250, 500 and 1000 mg/Kg bw
DIET PREPARATION
- Rate of preparation of diet (frequency): No data available
- Mixing appropriate amounts with (Type of food): No data available
- Storage temperature of food: No data available
VEHICLE
- Justification for use and choice of vehicle (if other than water): Water
- Concentration in vehicle: 0, 250, 500, or 1000 mg/kg/day
- Amount of vehicle (if gavage): No data available
- Lot/batch no. (if required): No data available
- Purity: No data available - Analytical verification of doses or concentrations:
- not specified
- Details on mating procedure:
- - Length of cohabitation: 2 weeks
- Duration of treatment / exposure:
- Total:110
Premating period -71 days
Mating period-14 days
Gestation period-21 days
Postpartum day -4. - Frequency of treatment:
- Daily
- Duration of test:
- 110
- Remarks:
- 0, 250, 500 and 1000 mg/kg/day
- No. of animals per sex per dose:
- Total no of animals-96
0 mg/kg/day - 12 male and 12 female
250 mg/kg/day- 12 male and 12 female
500 mg/kg/day- 12 male and 12 female
1000 mg/kg/day- 12 male and 12 female - Control animals:
- yes, concurrent vehicle
- Details on study design:
- No data available
- Maternal examinations:
- Body weight and food consumption, gross pathology and histopathology was observed.
- Ovaries and uterine content:
- Implantation sites and ovarian corpora lutea also examined.
- Fetal examinations:
- Pup viability, individual pup weights, litter sizes.and clinical signs were observed at birth and on lactation day 4.
- Statistics:
- No data available
- Indices:
- Mean Number of Pups/Litter and Offspring viability indices was observed on day 0 and 4 of lactation were examined.
- Historical control data:
- No data available
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality:
- not specified
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Neuropathological findings:
- not specified
- Histopathological findings: non-neoplastic:
- not specified
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
- Details on results:
- Body weight: Significant reductions in body weight in P1 animals were observed at 1000 mg/kg/day. Weight gain of pregnant females was less at 1000 mg /kg/day from gestational day 1 to day 7 (87.5% of control) but similar to the other groups at intervals after gestational day 7.
Food consumption: Significant reductions in food consumption were observed in P1 male and female rats. - Number of abortions:
- not specified
- Pre- and post-implantation loss:
- effects observed, treatment-related
- Total litter losses by resorption:
- effects observed, treatment-related
- Early or late resorptions:
- not specified
- Dead fetuses:
- not specified
- Changes in pregnancy duration:
- not specified
- Description (incidence and severity):
- Migrated Data from removed field(s)
Field "Effects on pregnancy duration" (Path: ENDPOINT_STUDY_RECORD.DevelopmentalToxicityTeratogenicity.ResultsAndDiscussion.ResultsMaternalAnimals.MaternalDevelopmentalToxicity.EffectsOnPregnancyDuration): not specified - Changes in number of pregnant:
- not specified
- Other effects:
- not specified
- Details on maternal toxic effects:
- Reproductive function: estrous cycle: Significant decrease in corpora lutea counts and subsequently lower implantation site counts and litter sizes were observed at 1000 mg/kg/day treated female rat.
Reproductive performance: No effect on Number of Pups/Litter were observed in treated female rats. - Dose descriptor:
- NOAEL
- Effect level:
- 500 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- body weight and weight gain
- food consumption and compound intake
- pre and post implantation loss
- other: No adverse effect
- Fetal body weight changes:
- not specified
- Description (incidence and severity):
- Migrated Data from removed field(s)
Field "Fetal/pup body weight changes" (Path: ENDPOINT_STUDY_RECORD.DevelopmentalToxicityTeratogenicity.ResultsAndDiscussion.ResultsFetuses.FetalPupBodyWeightChanges): not specified - Reduction in number of live offspring:
- no effects observed
- Changes in sex ratio:
- no effects observed
- Changes in litter size and weights:
- not specified
- Changes in postnatal survival:
- not specified
- External malformations:
- not specified
- Skeletal malformations:
- not specified
- Visceral malformations:
- not specified
- Other effects:
- not specified
- Details on embryotoxic / teratogenic effects:
- Viability: No effect on viability of treated pups were observed till day 4 of lactation as compared to control.
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No effect on Number of Pups/Litter and viability
- Abnormalities:
- not specified
- Developmental effects observed:
- no
- Treatment related:
- not specified
- Relation to maternal toxicity:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
- Conclusions:
- NOAEL was considered to be 500 mg/kg bw/day for P1 generation and 1000 mg/kg bw/day for F1 generation when male and female rats were treated with Methylamine hydrochloride (Methanaminium chloride) orally by gavage for 110 days.
- Executive summary:
In a repeated dose reproduction –development toxicity study, male and female rats were treated with Methylamine hydrochloride (Methanaminium chloride) in the concentration of0, 250, 500 and 1000 mg/kg/day orally by gavage in water. Test was conducted as per OECD 422. Significant decrease in body weight of P1 animals were observed at 1000 mg/kg/day. Weight gain of pregnant females was less at 1000 mg /kg/day from gestational day 1 to day 7 (87.5% of control) but similar to the other groups at intervals after gestational day 7. Significant reductions in food consumption were observed in P1 male and female rats. Similarly, significant decrease in corpora lutea counts and subsequently lower implantation site counts and litter sizes were observed at 1000 mg/kg/day treated female rat. But, No effect on Number of Pups/Litter were observed in treated female rats. In addition, No effect develpmental toxicity was observed in treated pups such as on viability till day 4 of lactation as compared to control at 250, 500 and 1000 mg/kg bw/day. Therefore, NOAEL was considered to be 500 mg/kg bw/day for P1 generation and 1000 mg/kg bw/day for F1 generation whenmale and female rats were treated withMethylaminehydrochloride (Methanaminium chloride) orally by gavage for 110 days.
Reference
MATBRNAL GROUP: |
II-0 |
IV-0 |
VI-0 |
VIII-0 |
DOSAGB{MG/KG/DAY): |
0 |
250 |
500 |
1000 |
CORPORA LUTEA COUNTS |
14.8 |
14.5 |
15.1 |
11.4* |
Standard Deviation(No. in group) |
2.3(12) |
2.1(11) |
1.8 (12) |
3.3(10) |
MEAN NUMBER OF PUPS/LITTER |
|
|
|
|
Born |
12.8 |
13.2 |
13.9 |
9.8 |
Born Alive |
12.8 |
13.0 |
13.9 |
9.8 |
Day 4 |
12.8 |
12.0 |
13.9 |
9.7 |
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- chronic
- Species:
- rat
- Quality of whole database:
- Data is Klimisch 4 and from study report
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Developmental toxicity: Oral
In study, Methanaminium chloride has been investigated for developmental toxicity. Study based on in vivo experiment in rodents, i.e. most commonly in rats for Methanaminium chloride.
In a repeated dose reproduction –development toxicity study, male and female rats were treated with Methylaminehydrochloride (Methanaminium chloride) in the concentration of0, 250, 500 and 1000 mg/kg/day orally by gavage in water. Test was conducted as per OECD 422. Significant decrease in body weight of P1 animals were observed at 1000 mg/kg/day. Weight gain of pregnant females was less at 1000 mg /kg/day from gestational day 1 to day 7 (87.5% of control) but similar to the other groups at intervals after gestational day 7. Significant reductions in food consumption were observed in P1 male and female rats. Similarly, reproductive toxicity was observed in treated female rats at 1000 mg/kg bw such as significant decrease in corpora lutea counts and subsequently lower implantation site counts and litter sizes were observed at 1000 mg/kg/day treated female rat. But, No effect on Number of Pups/Litter were observed in treated female rats. In addition, No effect on viability of treated pups were observed till day 4 of lactation as compared to control at 250, 500 and 1000 mg/kg bw/day. Therefore, NOAEL was considered to be 500 mg/kg bw/day for P1 generation and 1000 mg/kg bw/day for F1 generation when male and female rats were treated with Methylaminehydrochloride (Methanaminium chloride) orally by gavage for 110 days.
Thus, based on the above study on Methanaminium chloride and by conceding the weight of evidence, Methanaminium chloride can be “Not classified” for developmental toxicity.
Justification for classification or non-classification
Based on the above study on Methanaminium chloride and by conceding the weight of evidence, Methanaminium chloride can be “Not classified” for reproductived and Developmental toxicity.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.